Implementing robust amyloid PET quantification in multi‐center studies: AMYPAD approach to address data acquisition, processing, interpretation and data sharing challenges

Abstract INTRODUCTION Amyloid‐positron emission tomography (PET) is pivotal to Alzheimer's management, with the Centiloid standardizing measurements across tracers. AMYPAD trials (Diagnostic and Patient Management Study [DPMS] and Prognostic and Natural History Study [PNHS]) aimed to validate robust...

Повний опис

Бібліографічні деталі

Автори:	Ariane Bollack, Mahnaz Shekari, Lyduine E. Collij, Emma Luckett, David Valléz García, Pawel Markiewicz, Robin Wolz, Maqsood Yaqub, Alle Meije Wink, Rossella Gismondi, Andrew Stephens, Pieter Jelle Visser, Anja Mett, Alexander Drzezga, Christopher Buckley, Juan Domingo Gispert, Gill Farrar, Frederik Barkhof
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Wiley 2025-10-01
Серія:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Предмети:	Alzheimer's amyloid Centiloid PET quantification
Онлайн доступ:	https://doi.org/10.1002/trc2.70190
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!